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Child Allergic Symptoms and Mental Well-Being: The Role of Maternal
Anxiety and Depression*
Alison Teyhan, PhD, Bruna Galobardes, PhD, and John Henderson, MD
Objective To determine whether maternal mental health mediates the relationship between eczema or asthma
symptoms and mental well-being in children.
Study design Analysis of 7250 children from the Avon Longitudinal Study of Parents and Children. Child mental
well-being at 8 years was measured by the Strengths and Difficulties Questionnaire. Binary outcomes were high
‘internalizing’ (anxious/depressive) and ‘externalizing’ (oppositional/hyperactive) problems (high was >90th percen-
tile). Child rash and wheeze categories were ‘none’; ‘early onset transient’ (infancy/preschool only); ‘persistent’ (in-
fancy/preschool and at school age); and ‘late onset’ (school age only). Maternal anxiety and depression were
reported during pregnancy and when child was 8 years old.
Results Persistent wheezing symptoms were associated with high externalizing (OR 1.74, 95%CI, 1.41-2.15) and
internalizing (1.67, 1.35-2.06) problems compared with never wheeze. Maternal anxiety and depression, and dis-
rupted child sleep, attenuated these associations. Persistent rash (externalizing: 1.74, 1.40-2.15; internalizing:
1.42, 1.16-1.74) and late onset rash (externalizing: 1.62, 1.17-2.25; internalizing: 1.46, 1.07-1.99) symptoms were
associated with poorer mental well-being compared with no rash at any age. Maternal anxiety and depression,
particularly when child was aged 8 years rather than during pregnancy, accounted for the association with internal-
izing symptoms and partly for externalizing symptoms. Sleep disruption did not mediate the association.
ConclusionsMaternal anxiety and depression may mediate the association between child rash and wheeze and
child mental well-being. (J Pediatr 2014;165:592-9).
C
hildren with eczema and asthma have been reported to have poorer mental well-being than healthy children; childhood
asthma has been associated with anxiety, depression, emotional and behavioral problems, and treatment for a mental
health problem,1-9 and childhood eczema with increased emotional problems and a higher risk of attention deficit/hy-
peractivity disorder (ADHD).10-14
Childhood eczema and asthma are also associated with maternal anxiety and depression; mothers who are anxious or
depressed during pregnancy, the postpartum period, and beyond are at increased risk of having a child with asthma or
wheezing.15-18 There is also evidence of reverse causation; caring for a child with eczema or asthma is associated with higher
levels of anxiety, depression, sleep deprivation, and reduced quality of life for the child’s parents and family.19-24
Therefore, as children with eczema and asthma are more likely to have a mother with anxiety or depression compared with
healthy children, maternal mental health may be an important mediator of the association between eczema and asthma and
child mental well-being. A better understanding of the role of maternal mental health could help elucidate the mechanisms
that underpin the association between eczema and asthma and child mental well-being, and if causal, could aid the development
of interventions to improve the mental and physical health of children affected by these conditions.25
Few previous studies on the mental well-being of children with eczema or asthma have considered maternal mental health.
Additional limitations to the existing literature include the frequent use of small, clinic-based, convenience samples, a lack of
inclusion of potentially important confounders, and few studies focusing on younger children.11,26,27 Few studies have consid-
ered both eczema and asthma despite the frequent co-occurrence of these conditions. To address these limitations, we used data
from a large, longitudinal, population-based birth cohort. We hypothesized that maternal anxiety and depression wouldFrom the School of Social and Community Medicine,
University of Bristol, Bristol, United Kingdom
Supported by the UK Medical Research Council and
the United Kingdom Wellcome Trust (092731) and the
University of Bristol (United Kingdom) core support for
ALSPAC. B.G. is funded by a Wellcome Trust fellowship
(089979). The authors declare no conflicts of interest.mediate the association between rash and wheeze and child mental well-being
(Figure; available at www.jpeds.com). Our first aim was to determine whether
rash or wheeze symptoms were associated with internalizing (ie, anxious and
depressive) or externalizing (ie, oppositional and hyperactive) behaviors at the
age of 8 years, and whether duration of symptoms was an important factor.
Our second aim was to determine whether these associations remained after
adjustment for maternal anxiety and depression.Portions of this study were presented at the European
Public Health Conference, Brussels, Belgium, 13-16th
November 2013.
0022-3476/$ - see front matter. Copyright ª 2014 The Authors.
Published by Elsevier Inc.
http://dx.doi.org/10.1016/j.jpeds.2014.05.023
*This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).
ADHD Attention deficit/hyperactivity disorder
ALSPAC Avon Longitudinal Study of Parents and Children
SEP Socioeconomic position
TDS Total difficulties score
592
Vol. 165, No. 3  September 2014Methods
Subjects were participants in the Avon Longitudinal Study of
Parents and Children (ALSPAC). Details on ALSPAC have
been published previously,28 and a fully searchable data dic-
tionary is available online (www.bristol.ac.uk/alspac/). In
brief, ALSPAC recruited pregnant women with expected
dates of delivery between April 1, 1991 and December 31,
1992 who lived in a defined geographic area (Avon, United
Kingdom). The children have been studied throughout their
lives using maternal or self-report questionnaires and, from
the age of 7 years, approximately annual research clinic visits.
There were 14 062 live births, 13 988 children were alive at
1 year and over 7000 mothers completed the 8-year question-
naire. The study sample in this paper comprises the 7250 sin-
gletons with outcome data at 8 years of age. Ethical approval
for the study was obtained from the ALSPAC Ethics and Law
Committee and the Local Research Ethics Committees.
Measures
Exposure - Child Rash,Wheeze, and Atopy. Child rash
and wheeze symptoms were reported in mailed, self-
completion questionnaires sent to the mother when her child
was aged 6 months, 18 months, 2 years 6 months, 3 years
6 months, 4 years 9 months, 5 years 9 months, 6 years
9 months, and 7 years 7 months (Table I; available at www.
jpeds.com). When questionnaires contained more than 1
question about wheeze or rash, a symptom was coded as
being present if the mother reported yes to any 1 of the
questions. The time periods covered by the questionnaires
were categorized as infancy (up to 18 months), preschool
(18 months up to 4 years 9 months), and school age
(4 years 9 months up to 7 years 7 months). For each time
period, symptoms were coded as being present if the
mother reported that the child had the symptom in at least
1 questionnaire. For rash and wheeze separately, symptoms
were categorized as ‘none’ (no symptoms in any time
period); ‘early onset, transient’ (symptoms in infancy and/
or preschool only); ‘persistent’ (symptoms in infancy and/
or preschool, and at school age); and ‘late onset’
(symptoms at school age only). Atopy status was known
for 5004 children in our sample who attended an ALSPAC
clinic when aged 7.5 years; atopy was determined by skin
prick testing and defined as a positive response ($2 mm
weal) to any one of Dermatophagoides pteronyssinus, grass,
or cat allergen with a negative response to diluent solution.
As previously reported, this definition identified >95% of
subjects with any positive response to a wider panel of
allergens.29
Outcome—Child Mental Well-Being. Child mental
well-being at age 8 years 1 month was maternally reported
using the parental version of the Goodman Strengths
and Difficulties Questionnaire, a validated behavioral
screening tool for children and adolescents.30 The peer
and emotion subscales can be summed to give an internal-
izing problems score (range 0-20), and the hyperactivityand conduct subscales summed to give an externalizing
problems score (range 0-20).31 All 4 subscales can be
summed to give a total difficulties score (TDS) (range
of 0-40); a higher score reflects more difficulties. For
each of the TDS, externalizing and internalizing scores,
children were classified as having a high score or not
(high defined as >90th percentile). The cut-offs for a
high score were $7 for internalizing, $10 for external-
izing, and $15 for TDS.
Other Variables. Maternal anxiety and depression were
measured in pregnancy and at the outcome time-point
(when child was 8 years old). Depression was measured by
the Edinburgh Postnatal Depression Scale. Although this
measure was originally designed for use with postnatal
women, none of the 10 items is specific to this period and
it has been validated for use at other times32; it was chosen
as it does not contain somatic items that could confound
normal symptoms in pregnancy with depression. Anxiety
was measured in pregnancy by the 8 items of the anxiety sub-
scale of the Crown-Crisp Experiential Index33 and 8 years
later, by the 20-trait anxiety items of the State-Trait Anxiety
Inventory.34 Quartiles of depression and anxiety scores were
calculated for use in analyses as they were not normally
distributed.
A number of other child, mother, and socioeconomic vari-
ables thought to be potential confounders or mediators
(based on previous literature or on theoretical grounds)
were also included in analyses. Child variables were mater-
nally reported: sex; ethnicity (White, non-White [no further
disaggregation was possible due to small numbers]); age at
outcome; and child wakes at night (no, once, twice or
more). Socioeconomic position (SEP) was reported during
pregnancy: highest maternal education (university degree,
A level, O level, vocational/none); housing tenure (owned/
mortgaged, privately rented, council rented, other); and
financial difficulties (quartiles of score with range 0-40,
where 0 is no financial difficulties). Maternal smoking (no,
yes) was reported during pregnancy and at the outcome
time point, and maternal insufficient sleep (no, yes) when
the child was aged 7 years.
Missing Data
Multiple imputation using chained equations was used to
replace missing exposure and confounder data with predic-
tions based on information observed in the sample. The per-
centage of missing data was below 10% for most variables
(Table II; available at www.jpeds.com); 47% of the
children had complete data, with another 40% having
between 1 and 4 missing variables. Twenty imputed
datasets were created and analyzed using mi estimate
commands in Stata 13 (StataCorp, College Station, Texas).
Complete case analysis was also performed; results were
consistent with those from the imputed data and are
available from authors on request. Atopy data were not
imputed; a separate complete case analysis was performed
for this exposure.593
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c2 tests were used to assess whether distributions of the
outcome and confounder variables differed by rash or wheeze
status. To determine whether maternal mental health could
be a mediator in the relationship between child rash or
wheeze and child mental well-being, we first used multivari-
able logistic regression models to test for an association be-
tween the exposure and the potential mediator (child rash/
wheeze and maternal anxiety/depression) and between the
potential mediator and the outcome (maternal anxiety/
depression and child mental well-being).35 Multivariable lo-
gistic regression models were then used to model the associ-
ation between child rash and wheeze and the child mental
well-being outcomes. Eight multivariable logistic regression
models were fitted for each binary outcome (high TDS,
high internalizing problems, high externalizing problems).
All models adjusted for baseline confounders (child demo-
graphics, SEP, mother’s age at delivery). Model 1 added
rash and wheeze individually to these baseline confounders;
model 2 then included both rash and wheeze together.
Models 3 and 4 added maternal anxiety and depression, in
pregnancy and at the outcome time point, respectively, to
the variables in model 2. Model 5 adjusted for maternal anx-
iety and depression at both time points. Finally, we included
maternal smoking (model 6), maternal sleep (model 7), and
child sleep (model 8). Interaction terms were fitted to test
whether the relationship between rash/wheeze and the child
mental well-being outcomes differed by child sex; these
were not significant and so models were adjusted for sex
but not stratified. We also tested for interactions between
rash and wheeze, and between maternal mental health and
rash and wheeze; none of these were significant and so are
not included in the models presented.
Results
The 7250 children (3681 boys and 3569 girls) had a mean age
of 8.2 years at outcome assessment. Compared with the
excluded sample (children with no outcome data), study
children were more likely to be of higher SEP and to have
ever had a rash. The mothers of the study children reported
lower anxiety and depression than the mothers of the
excluded sample and were less likely to smoke (Table III;
available at www.jpeds.com).
In the study sample, more mothers reported that their
child had ever had a rash (71%) than wheeze (46%). The
patterning of symptoms by maternal SEP differed for rash
and wheeze (Table IV). Mothers whose child had wheeze
were more likely to have reported financial difficulties and
were less likely to have owned their own home. In contrast,
mothers whose child had early onset rash were the most
likely to be educated to degree level. Children with a
persistent rash were the most likely to have had wheeze,
and children with wheeze at school age were the most likely
to have had a rash. Children with wheeze were more likely
to have a mother who smoked, but there was no
association between maternal smoking and child rash status594(Table IV). Children with wheeze and rash at school age
were the most likely to wake during the night (Table IV).
Maternal sleep was correlated with child sleep; of mothers
who reported insufficient sleep, 21% said their child woke
at least once at night compared with 14% of mothers who
reported sufficient sleep. Maternal anxiety and depression
scores, in pregnancy and at the outcome time point, were
associated with child rash and wheeze and with child
externalizing, internalizing, and TDS (Tables IV and V and
Figure; Table V available at www.jpeds.com).
Internalizing and externalizing continuous scores were
moderately correlated (r = 0.39). However, most of the chil-
dren with a high score on 1 measure did not have a high score
on the other measure; 482 children had a high externalizing
score only, 548 children had a high internalizing score only,
and 257 had both a high externalizing and internalizing score.
One-fifth of the children (20.4%) who had a skin prick
test had a positive reaction, indicating atopy. Children
with early onset transient rash (OR 1.61, 95% CI, 1.29-
2.01) and persistent rash (3.31, 2.70-4.05) were more likely
to be atopic than children who had never had a rash; there
was no difference for late onset rash. For wheeze, those
with persistent (4.49, 3.74-5.40) and late onset (3.24, 2.38-
4.41) wheeze were more likely to be atopic than those
with never wheeze, but there was no difference for early
onset transient wheeze.
Children with rash had elevated odds of having a high
internalizing, externalizing, and TDS relative to those who
had never had a rash. ORs were higher for externalizing prob-
lems than internalizing problems, and were higher for those
with a rash at school age (whether persistent or late onset)
compared with those with early onset transient symptoms
(Table VI, model 1). Children with persistent wheeze, and
to a lesser extent early onset transient wheeze, had higher
odds of internalizing and externalizing problems, and of
having a high TDS, than children who had never wheezed.
There was no association between late onset wheeze and
any of the mental well-being outcomes. Rash and wheeze
were associated with the outcomes independent of each
other, although including both in the same model did
attenuate associations for persistent rash and persistent
wheeze for all outcomes (Table VI, model 2).
Maternal anxiety and depressionwhen the child was 8 years
old, but not during pregnancy, accounted for the association
between child rash and internalizing symptoms and partly for
the association with externalizing symptoms (Table VI,
models 3 and 4). On the other hand, maternal anxiety and
depression during pregnancy, rather than in childhood,
appeared more relevant in accounting for the association
between internalizing and externalizing symptoms and
child persistent wheeze. Further adjustment for maternal
smoking or maternal sleep did not modify these
associations (Table VI, model 6 and 7). Child sleep
explained some of the association between the outcomes
and persistent wheeze, but not rash (Table VI, model 8).
In the subsample of children who had their atopy status
determined by skin prick test (n = 5004), there was noTeyhan, Galobardes, and Henderson
Table IV. Summary of child mental well-being outcomes and confounders/mediators, overall and by rash and wheeze
status
Child’s age when
questionnaire
posted to mother
Overall
(n = 7250,
100%)
Rashz Wheezez
None
Early onset
transient Persistent
Late
onset None
Early onset
transient Persistent
Late
onset
Outcome - child mental
well-being (SDQ)
TDS (% high)*,† 8 years 1 month 10.5 8.4 10.1 12.2 12.7 8.8 11.2 15.4 10.9
Internalizing problems
score (% high)*,†
8 years 1 month 11.1 9.4 10.5 12.7 12.9 9.4 11.8 15.7 12.2
Externalizing problems
score (% high)*,†
8 years 1 month 10.2 7.9 10.0 12.0 11.6 8.6 10.6 16.1 8.7
Exposures - child rash and
wheeze status
Wheeze*
None (%) birth to 7 years 7 months 53.6 62.9 53.1 45.3 56.5
Early onset transient (%) 28.0 25.8 31.0 27.0 28.2
Persistent (%) 14.1 7.8 12.3 22.1 9.8
Late onset (%) 4.4 3.5 3.5 5.6 5.5
Rash†
None (%) birth to 7 years 7 months 29.0 34.1 26.8 16.1 23.5
Early onset transient (%) 29.9 29.7 33.2 26.2 24.1
Persistent (%) 33.4 28.2 32.2 52.4 42.8
Late onset (%) 7.6 8.0 7.7 5.3 9.6
Other variables
Maternal age at delivery (mean)*,† 29.1 28.9 28.9 29.2 29.6 29.2 28.9 28.7 29.2
Socioeconomic status
Maternal education (% with
university degree)*
Pregnancy 16.4 12.9 17.4 19.0 14.3 17.0 15.4 14.7 19.5
Housing tenure (% with
mortgage/owned)†
Pregnancy 82.0 81.3 82.4 82.7 80.1 84.9 80.0 75.6 78.9
Financial difficulties (% none)† Pregnancy 40.3 40.7 40.5 40.0 39.5 44.3 35.5 35.3 37.5
Mental health in pregnancy
Depression Score (EPDS)
(% Q4 - high)*,†
Pregnancy 24.3 23.1 24.7 25.9 20.3 20.6 27.7 31.2 25.6
Anxiety score (% Q4 - high)*,† Pregnancy 19.1 18.2 18.5 20.8 17.9 15.9 22.6 24.5 19.1
Mental health at outcome time point
Depression score (EPDS)
(% Q4 - high)*,†
8 years 1 month 23.5 20.3 23.1 25.8 27.6 21.8 24.7 27.3 24.3
Anxiety score (% Q4 - high)*,† 8 years 1 month 24.3 21.9 24.1 25.7 28.4 23.1 25.2 27.0 25.2
Maternal smoking
Yes in pregnancy (%)† Pregnancy 20.3 20.4 21.8 18.8 21.2 17.2 23.7 25.0 21.9
Yes at outcome time point (%)† 8 years 1 month 19.4 19.1 21.2 18.1 19.2 16.5 22.9 22.9 21.5
Maternal sleep
Insufficient sleep (%)*,† 7 years 1 month 38.0 34.0 38.8 41.0 37.4 34.7 40.3 45.5 40.8
Child sleep
Wakes at night
(% $1 times per night)*,†
6 years 9 months 16.8 15.0 16.0 18.0 20.9 15.2 16.4 22.1 21.3
EPDS, Edinburgh Postnatal Depression Scale; SDQ, Strengths and Difficulties Questionnaire.
*Difference between rash categories in distribution of variable statistically significant (P < .05).
†Difference between wheeze categories in distribution of variable statistically significant (P < .05).
zNumbers in each rash and wheeze category not shown as they differ across imputed datasets.
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internalizing (OR 0.91, 95% CI, 0.72-1.15), externalizing
(0.91, 0.72-1.16), or total difficulties (1.03, 0.82-1.30) score
in age-adjusted models. Complete confounder data was
available for 3584 of these children; adjustment made little
difference to the associations observed (Table VII; available
at www.jpeds.com).
Discussion
Both rash and wheeze status were related to child mental
well-being at the age of 8 years in our large, population-
based cohort study; persistent and late onset rash, and persis-Child Allergic Symptoms and Mental Well-Being: The Role of Matent wheeze, were associated with both internalizing and
externalizing symptoms. These results confirm, in a large
prospective study, previous results of increased internal-
izing5,10,14,26,27 and externalizing11,36 problems in children
with eczema and asthma. We have demonstrated the impor-
tance of including measures of maternal anxiety and depres-
sion, both during and after pregnancy, when examining the
relationship between rash and wheeze and child mental
well-being. For persistent and late onset rash, we found
that maternal anxiety and depression, particularly after the
birth of the child rather than during pregnancy, accounted
for the association with internalizing symptoms and partly
for externalizing symptoms. Worse sleep did not mediateternal Anxiety and Depression 595
Table VI. Association between child rash and wheeze status and child mental well-being at age 8 years
OR (95% CI)
Model 1
Rash and wheeze
in separate models
Model 2
Rash and wheeze
in same model
Model 3
M2 + maternal
anxiety and depression
in pregnancy
Model 4
M2 + maternal anxiety
and depression when
child 8 years
Model 5
M2 + maternal
anxiety and
depression
at both time points
Model 6
M5 + maternal
smoking
Model 7
M5 + maternal
sleep
Model 8
M5 + child
sleep
High internalizing symptoms
Rash (reference = no rash)
Early onset transient 1.14 (0.92-1.42) 1.10 (0.89-1.38) 1.09 (0.88-1.36) 1.04 (0.83-1.31) 1.04 (0.83-1.31) 1.05 (0.83-1.31) 1.03 (0.82-1.30) 1.04 (0.83-1.30)
Persistent 1.42 (1.16-1.74)† 1.31 (1.07-1.61)† 1.28 (1.04-1.57)* 1.21 (0.98-1.50) 1.21 (0.98-1.50) 1.21 (0.98-1.50) 1.20 (0.97-1.48) 1.20 (0.97-1.49)
Late onset 1.46 (1.07-1.99)* 1.43 (1.05-1.95)* 1.44 (1.06-1.98)* 1.28 (0.93-1.77) 1.30 (0.94-1.79) 1.30 (0.94-1.79) 1.30 (0.94-1.80) 1.27 (0.92-1.75)
Wheeze (reference = no wheeze)
Early onset transient 1.22 (1.02-1.46)* 1.21 (1.01-1.44)* 1.15 (0.96-1.38) 1.17 (0.97-1.40) 1.15 (0.96-1.38) 1.15 (0.96-1.38) 1.14 (0.95-1.37) 1.15 (0.95-1.38)
Persistent 1.67 (1.35-2.06)z 1.58 (1.28-1.96)z 1.48 (1.19-1.83)z 1.54 (1.23-1.92)z 1.50 (1.20-1.87)z 1.50 (1.20-1.87)z 1.47 (1.18-1.84)† 1.45 (1.16-1.81)†
Late onset 1.30 (0.89-1.91) 1.25 (0.85-1.84) 1.20 (0.81-1.76) 1.21 (0.82-1.78) 1.20 (0.81-1.77) 1.20 (0.81-1.78) 1.18 (0.80-1.75) 1.16 (0.79-1.72)
High Externalizing Symptoms
Rash (reference = no rash)
Early onset transient 1.33 (1.06-1.67)* 1.29 (1.03-1.63)* 1.28 (1.02-1.62)* 1.22 (0.97-1.54) 1.22 (0.97-1.54) 1.21 (0.96-1.53) 1.21 (0.96-1.53) 1.21 (0.96-1.52)
Persistent 1.74 (1.40-2.15)z 1.61 (1.29-2.00)z 1.58 (1.27-1.97)z 1.47 (1.17-1.83)† 1.47 (1.18-1.84)† 1.48 (1.18-1.85)† 1.46 (1.17-1.83)† 1.46 (1.17-1.84)†
Late onset 1.62 (1.17-2.25)† 1.60 (1.15-2.22)† 1.62 (1.17-2.25)† 1.43 (1.03-2.01)* 1.45 (1.04-2.03)* 1.44 (1.03-2.02)* 1.45 (1.04-2.03)* 1.41 (1.00-1.98)*
Wheeze (reference = no wheeze)
Early onset transient 1.13 (0.93-1.37) 1.10 (0.91-1.34) 1.07 (0.88-1.30) 1.06 (0.87-1.29) 1.05 (0.86-1.29) 1.04 (0.85-1.27) 1.05 (0.86-1.28) 1.05 (0.86-1.28)
Persistent 1.74 (1.41-2.15)z 1.59 (1.28-1.97)z 1.52 (1.22-1.89)z 1.55 (1.25-1.94)z 1.54 (1.24-1.93)z 1.53 (1.23-1.91)z 1.52 (1.22-1.90)z 1.47 (1.18-1.84)†
Late onset 0.99 (0.62-1.57) 0.93 (0.59-1.47) 0.90 (0.57-1.44) 0.89 (0.56-1.41) 0.88 (0.56-1.41) 0.87 (0.55-1.39) 0.88 (0.55-1.40) 0.85 (0.54-1.36)
High TDS
Rash (reference = no rash)
Early onset transient 1.25 (0.99-1.59) 1.21 (0.96-1.54) 1.20 (0.95-1.52) 1.14 (0.90-1.45) 1.15 (0.90-1.46) 1.15 (0.90-1.45) 1.13 (0.89-1.44) 1.13 (0.89-1.44)
Persistent 1.61 (1.31-1.98)z 1.49 (1.21-1.84)z 1.46 (1.18-1.81)z 1.36 (1.09-1.68)† 1.36 (1.10-1.69)† 1.37 (1.10-1.70)† 1.35 (1.08-1.67)† 1.35 (1.09-1.68)†
Late onset 1.68 (1.23-2.29)† 1.65 (1.21-2.25)† 1.69 (1.23-2.31)† 1.47 (1.06-2.03)* 1.50 (1.08-2.07)* 1.50 (1.08-2.07)* 1.50 (1.09-2.08)* 1.45 (1.04-2.01)*
Wheeze (reference = no wheeze)
Early onset transient 1.20 (1.00-1.44) 1.17 (0.98-1.41) 1.12 (0.93-1.35) 1.13 (0.93-1.37) 1.11 (0.92-1.35) 1.11 (0.91-1.35) 1.11 (0.91-1.34) 1.11 (0.91-1.35)
Persistent 1.66 (1.34-2.04)z 1.54 (1.24-1.91)z 1.43 (1.15-1.78)z 1.49 (1.20-1.87)z 1.46 (1.17-1.83)† 1.46 (1.16-1.82)† 1.42 (1.14-1.78)† 1.38 (1.10-1.73)†
Late onset 1.24 (0.81-1.90) 1.18 (0.77-1.80) 1.13 (0.73-1.73) 1.13 (0.73-1.74) 1.12 (0.72-1.73) 1.11 (0.72-1.72) 1.10 (0.71-1.70) 1.07 (0.69-1.66)
All models adjust for child sex, age, ethnicity, mother’s age, maternal education, financial difficulties, housing tenure.
Model 1: separate model for rash and wheeze status.
Model 2: rash status, wheeze status.
Model 3: Model 2 plus maternal anxiety and depression in pregnancy.
Model 4: Model 2 plus maternal anxiety and depression when child aged 8 years.
Model 5: Model 2 plus maternal anxiety and depression in pregnancy and when child aged 8 years.
Model 6: Model 5 plus maternal smoking in pregnancy and when child aged 8 years.
Model 7: Model 5 plus maternal sleep.
Model 8: Model 5 plus child sleep.
*P < .05.
†P < .01.
zP < .001.
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September 2014 ORIGINAL ARTICLESthe association. However, maternal anxiety and depression at
both time points attenuated the association with persistent
wheeze. Worse child sleep also contributed to the association
with persistent wheeze.
In our study, children who only had symptoms in infancy
or preschool tended to have poorer mental well-being at
8 years compared with those with no symptoms at any age;
early onset transient wheeze was associated with more inter-
nalizing problems, and early onset transient rash with more
externalizing problems. Similarly, a large German cohort
study found that children who cleared their eczema by age
2 years tended to have more emotional and conduct prob-
lems at age 10 years than children who had never had
eczema.14 We found generally similar sized associations for
persistent and late onset rash, which contrasts with the
German study which found that emotional problems were
greater the longer eczema persisted14; age at outcome and
categories of symptom duration differed between the studies,
which may explain the different findings. We mutually
adjusted for rash and wheeze status to account for the fact
that these conditions often coexist, and found both symp-
toms to be independently associated with the outcomes.
There is limited evidence from previous literature on the rela-
tive impact of eczema and asthma on child mental well-being,
and findings are mixed. In the German study, eczema was
associated with mental well-being independent of atopic co-
morbidity but associations for asthma were not reported.14
In 4 other studies that included measures of both eczema
and asthma, all of which had ADHD as their outcome, 3
found only eczema was independently associated with
ADHD in fully adjusted models,12,13,36 but another study re-
ported that asthma, but not eczema, was associated with
ADHD.37
Our mediation model assumes that child rash and wheeze
predict maternal anxiety and depression, which in turn co-
occur with poor child mental well-being (ideally child mental
well-being would have been measured after maternal anxiety
and depression in order to truly establish mediation). As
maternal anxiety and depression in pregnancy occur before
child rash and wheeze develop, they cannot mediate the asso-
ciation; however, child rash and wheeze could be a mecha-
nism through which maternal depression and anxiety in
pregnancy predict later child well-being.
A true mediating mechanism could involve both behav-
ioral and biological pathways. Caregivers with poor mental
health feel less empowered to deal with their child’s condition
or to manage it effectively, are less knowledgeable about their
child’s medications, and their children are at increased risk of
poor medication adherence, increased hospitalization, and
lower asthma-related quality of life.38-42 Therefore, poor
mental health may impair a mother’s ability to cope with
the demands of her child’s condition, including adminis-
tering the appropriate treatment regimes, resulting in a wors-
ening of her child’s physical symptoms.43
Many children with asthma and eczema, and consequently
their parents, suffer from disrupted sleep,21,44-46 and previous
studies have reported that sleep quality is a key factor in theChild Allergic Symptoms and Mental Well-Being: The Role of Maassociation between eczema, asthma, and behavioral prob-
lems in children.13,44,47,48 In the present study, maternal
and child sleep were related, but only child sleep attenuated
the association between wheeze and internalizing and exter-
nalizing problems. Maternal mental health may, therefore,
have direct effects on a child’s mental health, as well as indi-
rect effects via poor disease management resulting in a wors-
ening of symptoms, which in turn leads to disrupted sleep
and an increase in behavioral difficulties. However, such
pathways are likely to be cyclical as poor mental well-being
in asthmatic children is associated with increased disease
severity over time.49 Furthermore, a child’s physical symp-
toms may affect how the mother parents her child; studies
have found perceived child vulnerability50 and negative
parenting behaviors51 to mediate the association between
parental depression and child internalizing symptoms in
children with asthma. This highlights the complexity of the
relationships between child physical symptoms and child
and maternal mental health.
In addition to the potential behavioral pathways described
above, there may be biological pathways linking eczema and
asthma to mental well-being. Eczema and asthma in children
are both associated with stress, which may be mediated by
common underlying immunologic mechanisms, such as
atopy and systemic inflammatory responses.11 It is thought
that systemic inflammatory responses and stress could influ-
ence behavior and emotions via effects on the brain.11,52
Maternal mental health could play a role in such a biological
pathway, as parental stress and depression have been repor-
ted to predict increases in a child’s inflammatory profile.41
There was no association between atopy and child mental
well-being in our study, suggesting that associations between
rash and wheeze and mental well-being were not mediated by
allergy; however, we did not have relevant biomarkers of sys-
temic inflammation to explore this pathway further.
Rather than a mediating mechanism, it is possible in this
observational analysis that the attenuating effect of maternal
mental health is due to confounding. For example, lower SEP
is associated with both maternal mental health and more
child wheeze. However, we found that the role of maternal
mental health remained after adjustment for three measures
of SEP. Furthermore, confounding by SEP is not likely given
the association between maternal SEP and child rash is in the
opposite direction. Mothers with poorer mental health are
more likely to smoke, and maternal smoking is associated
with both child asthma and eczema, and child mental
health.53 However, in this study maternal smoking did not
explain any of the excess risk of behavioral problems associ-
ated with child rash or wheeze.
A further potential explanation is reporting bias. A
mother’s mental health may influence how she perceives
and reports both her child’s symptoms and behavior.49
This is important as the majority of studies, including ours,
use maternal reports. All of our measures, except for atopy,
were maternally reported thereby raising the possibility of
bias from sharedmethod variance. Finally, associations could
be due to reverse causality as maternal mental health may beternal Anxiety and Depression 597
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have not been able to test for reverse causality in our study,
and it is difficult to disentangle these potential mechanisms
in observational studies.
If maternal anxiety and depression have a true mediating
role, treatment to improve maternal mental health could
optimize the well-being of children with asthma and
eczema. The idea of ‘treating the parents to heal the child’
has been proposed for children with asthma and eczema,
but a better understanding of the role of parental psycholog-
ical well-being in child health is needed.25 Although there is
some limited evidence that interventions, such as cognitive
behavioral therapy for anxiety disorders, can improve
asthma-related quality of life in both adults54 and chil-
dren,55 we are unaware of any intervention to date that
has examined the impact of improving maternal anxiety
and depression on the well-being of children with asthma
or eczema.
Strengths of this current study include the use of a large,
longitudinal, population-based cohort, and the inclusion of
several potentially important confounders. In addition, we
included both rash and wheeze, and demonstrated the
importance of accounting for the duration of symptoms
in the association of rash and wheeze with later mental
health. Our study also has limitations. We had no objective
measure of rash and wheeze severity, and not all reported
rash and wheeze will be due to eczema or asthma, which
may limit comparison with previous studies. However, the
wheeze questions are consistent with those used by the In-
ternational Study of Asthma and Allergies in Childhood
and are a reliable way of diagnosing asthma in large epide-
miologic studies where direct physician assessment would
not be feasible.56 Also, a subset of the children had their
skin assessed at an ALSPAC clinic when aged 49 months;
observed eczema was associated with maternally reported
child rash. It is possible that some children developed symp-
toms in the 6-month period between the last measure
of rash/wheeze status (at age 7 years 7 months) and the
outcome measures (at age 8 years) and so may have had
their symptom status misclassified; however, such errors
would lead to our estimates being conservative. Child sleep
quality was measured at age 6 years 9 months and maternal
sleep at age 7 years 1 month; these variables may not reflect
sleep quality at the outcome time point, particularly if
rash or wheeze symptoms changed after sleep quality was
measured. Lastly, in this study we have only considered
child mental well-being at age 8 years; we have not consid-
ered how mental well-being, or its associations with rash
and wheeze, develop over time.
In conclusion, maternal anxiety and depression explained
some of the association between child rash and wheeze and
externalizing and internalizing symptoms in childhood.
Further research would help determine whether this is
because maternal mental health mediates the association,
or whether it is due to reporting bias, confounding or reverse
causality. A better understanding of the role of maternal
mental health could help in the development of interventions598to improve the quality of life of affected children and their
families. n
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Figure. Theoretical model of role of maternal anxiety and
depression in association between child allergic symptoms
and child mental well-being.
Table I. ALSPAC questionnaire items on rash and wheeze
Child’s age when questionnaire sent to mother
“Has your child had..” (since birth for 6-month questionnaire, since the
previous questionnaire time point for all others)
Rash
6 months, 18 months 1. A rash in the joints and creases of his/her body (eg, behind the knees, under the arms)?
2. An itchy, dry, oozing or crusted rash on the face, forearms or shins?
2 years 6 months, 3 years 6 months, 4 year 9 months,
5 years 9 months, 6 years 9 months
1. An itchy, dry skin rash in the joints and creases of his/her body (eg, behind the knees,
elbows, under the arms)?
2. An itchy, dry rash on his hands?
3. An itchy, dry rash on his feet?
7 years 7 months 1. A rash?
Wheeze
6 months, 18 months, 2 years 6 months, 3 years 6 months,
4 years 9 months, 5 years 9 months, 6 years 9 months
1. Wheezing with whistling on his chest when he/she breathed?
2. Wheezing?
7 years 7 months 1. Wheezing?
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Table II. Description of missing data for each of the
exposure and confounder variables
n (%) missing (7250 = 100%)*
Child sex 0
Mother’s age at delivery 0
Child ethnic group 295 (4.1)
Housing tenure 186 (2.6)
Maternal education 184 (2.5)
Financial difficulties 363 (5.0)
Anxiety in pregnancy 719 (9.9)
Depression in pregnancy 624 (8.6)
Anxiety when child aged 8 years 536 (7.4)
Depression when child aged 8 years 139 (1.9)
Maternal smoking in pregnancy 63 (0.87)
Maternal smoking when child 8 years 27 (0.37)
Maternal sleep 701 (9.7)
Child sleep 800 (11.0)
Wheeze
6 months 323 (4.5)
18 months 310 (4.3)
2 years 6 months 490 (6.8)
3 years 6 months 484 (6.7)
4 years 9 months 495 (6.8)
5 years 9 months 702 (9.7)
6 years 9 months 740 (10.2)
7 years 7 months 599 (8.3)
Rash
6 months 374 (5.2)
18 months 321 (4.4)
2 years 6 months 547 (7.5)
3 years 6 months 480 (6.6)
4 years 9 months 886 (12.2)
5 years 9 months 1126 (15.5)
6 years 9 months 980 (13.5)
7 years 7 months 610 (8.4)
*The study sample was defined as singleton children with complete outcome data, n = 7250.
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Table III. Comparison of study population and those
with incomplete data
Sample* (n = 7250) Complete
case†
(n = 5513)
Excluded
samplez
(N = 6367)Imputed Unimputed
N = 7250
Child high internalizing
problems score
High (%) 11.1 11.1 10.6 /
N = 7250
Child high externalizing
problems score
High (%) 10.2 10.2 9.6 /
N = 7250
Child high TDS
High (%) 10.5 10.5 9.7 /
N = 6934 N = 2246
Child rashx
None (%) 29.0 30.5 30.8 37.4
Early onset
transient (%)
29.9 30.9 30.6 34.7
Early onset
persistent (%)
33.4 31.3 31.2 22.8
Late onset (%) 7.6 7.3 7.4 5.1
N = 6958 N = 2296
Child wheezex
None (%) 53.6 54.8 55.4 53.5
Early onset
transient (%)
28.0 27.6 27.2 30.5
Early onset
persistent (%)
14.1 13.5 13.3 13.0
Late onset (%) 4.4 4.1 4.1 3.0
N = 7250 N = 6367
Child sex
Female (%) 49.2 49.2 48.9 47.5
N = 6955 N = 4814
Child ethnic group
White (%) 96.3 96.4 96.9 92.9
N = 7250 N = 6367
Mother’s age at delivery
Mean (years) 29.1 29.1 29.3 26.7
N = 7064 N = 5639
Housing tenure
Owned/mortgaged (%) 82.0 82.3 85.2 62.0
Privately rented (%) 5.7 5.6 4.8 9.3
Council rented (%) 9.4 9.2 7.8 24.4
Other (%) 3.0 2.9 2.2 4.3
N = 7066 N = 5036
Maternal education
Degree (%) 16.4 16.6 17.1 7.6
A-level (%) 26.1 26.3 27.3 17.3
O-Level (%) 35.3 35.2 35.7 33.7
None/Vocational (%) 22.3 22.0 19.8 41.3
N = 6531 N = 4935
Anxiety in pregnancy
Lowest quartile (%) 31.6 31.8 32.8 28.3
Highest quartile (%) 19.1 18.9 18.2 24.8
N = 6626 N = 5034
Depression in pregnancy
Lowest quartile (%) 22.0 22.2 22.8 17.2
Highest quartile (%) 24.3 23.9 22.9 33.0
N = 6714 N = 212
Anxiety when child aged
8 years
Lowest quartile (%) 25.3 25.6 26.1 25.9
Highest quartile (%) 24.3 23.9 23.0 28.3
N = 7111 N = 253
(continued )
Table III. Continued
Sample* (n = 7250) Complete
case†
(n = 5513)
Excluded
samplez
(N = 6367)Imputed Unimputed
Depression when child
aged 8 years
Lowest quartile (%) 30.0 30.0 31.0 29.6
Highest quartile (%) 23.5 23.5 21.9 27.3
N = 7187 N = 5861
Maternal smoking in
pregnancy
Yes (%) 20.3 20.2 18.7 35.2
N = 7223 N = 5498 N = 294
Maternal smoking when
child 8 years
Yes (%) 19.4 19.4 18.1 22.8
N = 6549 N = 5165 N = 1514
Maternal sleep
Insufficient sleep (%) 38.0 38.0 37.7 39.8
N = 6450 N = 5121 N = 1639
Child wakes at night
Never (%) 83.2 83.6 84.3 82.3
Once (%) 14.3 14.2 13.8 14.0
Twice or more (%) 2.4 2.2 1.8 3.8
*The study sample was defined as singleton children with complete outcome data, n = 7250.
Missing covariates were imputed. Table compares imputed and unimputed variables for the
study sample. For the unimputed data, denominators differ by variable and are stated in the
Table. The imputed sample was used in analysis.
†The complete case population consists of singleton children who have complete outcome,
exposure, and key confounder data. This sample was used in a sensitivity analysis.
zThe 6367 children in the excluded sample are singletons alive at 1 year who do not have
outcome data; denominators differ by variable and are stated in the Table.
xFor the unimputed, complete case, and excluded samples, the overall rash and wheeze
variables were derived for children who had rash/wheeze reported at least once in each
time period.
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Table V. Association between maternal depression and anxiety and child mental well-being outcomes (high
internalizing, externalizing, and total difficulties)
OR (95% CI)*
High internalizing High externalizing High TDS
Pregnancy
Maternal depression
Low (Q1, reference)
Q2 1.28 (0.97-1.68) 1.10 (0.84-1.44) 1.03 (0.76-1.38)
Q3 1.73 (1.35-2.21)† 1.41 (1.09-1.83)† 1.66 (1.28-2.15)†
High (Q4) 2.58 (2.01-3.32)† 2.05 (1.59-2.64)† 2.69 (2.07-3.48)†
Maternal anxiety
Low (Q1, reference)
Q2 1.42 (1.11-1.81)† 1.03 (0.80-1.32) 1.19 (0.92-1.54)
Q3 1.92 (1.54-2.41)† 1.43 (1.14-1.79)† 1.87 (1.48-2.35)†
High (Q4) 2.75 (2.19-3.45)† 1.96 (1.56-2.46)† 2.65 (2.11-3.34)†
Outcome time point
Maternal depression
Low (Q1, reference)
Q2 1.53 (1.19-1.97)† 1.76 (1.36-2.28)† 1.85 (1.41-2.43)†
Q3 2.27 (1.78-2.89)† 2.18 (1.69-2.82)† 2.73 (2.10-3.55)†
High (Q4) 4.03 (3.23-5.04)† 4.04 (3.20-5.10)† 5.24 (4.11-6.67)†
Maternal anxiety
Low (Q1, reference)
Q2 1.42 (1.11-1.81)† 1.03 (0.80-1.32) 1.19 (0.92-1.54)
Q3 1.92 (1.54-2.41)† 1.43 (1.14-1.79)† 1.87 (1.48-2.35)†
High (Q4) 2.75 (2.19-3.45)† 1.96 (1.56-2.46)† 2.65 (2.11-3.34)†
*Adjusted for maternal age at birth, financial difficulties, maternal education, housing tenure.
†P < .05.
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Table VII. Association between child atopy status and child mental well-being at age 8 years
OR (95% CI)
Model 1
+ age
Model 2
M1 + SEP
Model 3
M2 + maternal
anxiety and
depression in
pregnancy
Model 4
M2 + maternal
anxiety and depression
when child 8 years
Model 5
M2 + maternal
anxiety and depression
at both time points
Model 6
M5 + maternal
smoking
Model 7
M5 + maternal
sleep
Model 8
M5 + child
sleep
Atopy (reference = no atopy)
Complete case N = 5004 N = 4619 N = 4295 N = 4322 N = 4029 N = 4018 N = 3780 N = 3709
High Internalizing score 0.91 (0.72-1.15) 0.89 (0.69-1.13) 0.92 (0.71-1.19) 0.88 (0.68-1.14) 0.89 (0.68-1.17) 0.89 (0.68-1.17) 0.84 (0.63-1.12) 0.81 (0.60-1.08)
High Externalizing score 0.91 (0.72-1.16) 0.95 (0.74-1.22) 0.93 (0.72-1.21) 0.88 (0.68-1.15) 0.88 (0.67-1.16) 0.89 (0.67-1.17) 0.86 (0.65-1.14) 0.86 (0.64-1.15)
High TDS 1.03 (0.82-1.30) 1.04 (0.81-1.33) 1.07 (0.83-1.38) 0.99 (0.76-1.28) 1.02 (0.78-1.34) 1.02 (0.78-1.35) 0.97 (0.73-1.29) 0.98 (0.74-1.32)
All models restricted to those
with complete data
N = 3584 N = 3584 N = 3584 N = 3584 N = 3584 N = 3584 N = 3584 N = 3584
High internalizing score 0.85 (0.64-1.13) 0.84 (0.63-1.12) 0.84 (0.62-1.12) 0.81 (0.60-1.09) 0.81 (0.60-1.09) 0.81 (0.61-1.10) 0.81 (0.60-1.09) 0.80 (0.59-1.08)
High externalizing score 0.85 (0.63-1.13) 0.85 (0.64-1.14) 0.85 (0.64-1.14) 0.85 (0.64-1.14) 0.83 (0.62-1.12) 0.84 (0.62-1.13) 0.84 (0.62-1.13) 0.83 (0.62-1.12)
High TDS 0.97 (0.73-1.29) 0.98 (0.74-1.31) 0.98 (0.74-1.31) 0.96 (0.71-1.29) 0.95 (0.71-1.28) 0.96 (0.71-1.29) 0.96 (0.71-1.29) 0.95 (0.71-1.28)
Model 1: child sex, age (at skin prick test and at outcome).
Model 2: Model 1 plus ethnicity, mother’s age, maternal education, financial difficulties, housing tenure.
Model 3: Model 2 plus maternal anxiety and depression in pregnancy.
Model 4: Model 2 plus maternal anxiety and depression when child aged 8 years.
Model 5: Model 2 plus maternal anxiety and depression in pregnancy and when child aged 8 years.
Model 6: Model 5 plus maternal smoking in pregnancy and when child aged 8 years.
Model 7: Model 5 plus maternal sleep.
Model 8: Model 5 plus child sleep.
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